| Medical Center Psychiatry | |
|
350 Park St 204 Bowling Green KY 42101-1784 | |
| (270) 843-5103 | |
| (270) 843-5104 |
| Full Name | Medical Center Psychiatry |
|---|---|
| Speciality | Psychiatry & Neurology |
| Location | 350 Park St, Bowling Green, Kentucky |
| Authorized Official Name and Position | Michele Lawless (EXECUTIVE VICE PRESIDENT / CFO) |
| Authorized Official Contact | 2707451500 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Medical Center Psychiatry Po Box 90010 Bowling Green KY 42102-9010 Ph: (270) 745-1100 | Medical Center Psychiatry 350 Park St 204 Bowling Green KY 42101-1784 Ph: (270) 843-5103 |
| NPI Number | 1184016123 |
|---|---|
| Provider Enumeration Date | 02/27/2015 |
| Last Update Date | 05/08/2023 |
| Certification Date | 05/08/2023 |
| Medicare PECOS PAC ID | 7719899947 |
|---|---|
| Medicare Enrollment ID | O20150402002095 |
News Archive
Postmenopausal estrogen-based hormone therapy lasting longer than ten years was associated with a decreased risk of Alzheimer's disease in a large study carried out at the University of Eastern Finland.
Medical education in sub-Saharan Africa is being revitalized and expanded through a U.S.-funded effort that is dramatically increasing enrollment, broadening curricula, upgrading Internet access and providing cutting-edge skills labs and other technologies.
European women suffering from breast cancer will soon have access to the breast cancer drug Arimidex after British authorities granted approval for the drug to be used in a wider range of European women with breast cancer.
Adams Respiratory Therapeutics, Inc. reports that the Food and Drug Administration (FDA) has announced that companies must stop manufacturing and distributing unapproved timed-release dosage forms containing guaifenesin.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184016123 | NPI | - | NPPES |
| 000000928950 | Other | KY | ANTHEM |
| 7100342590 | Medicaid | KY | |
| 7100346960 | Medicaid | KY | |
| 7100342580 | Medicaid | KY | |
| 7100365240 | Medicaid | KY |
| Provider Name | Charu Raghuvanshi |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1427145275 PECOS PAC ID: 9032018874 Enrollment ID: I20031231000291 |
News Archive
Postmenopausal estrogen-based hormone therapy lasting longer than ten years was associated with a decreased risk of Alzheimer's disease in a large study carried out at the University of Eastern Finland.
Medical education in sub-Saharan Africa is being revitalized and expanded through a U.S.-funded effort that is dramatically increasing enrollment, broadening curricula, upgrading Internet access and providing cutting-edge skills labs and other technologies.
European women suffering from breast cancer will soon have access to the breast cancer drug Arimidex after British authorities granted approval for the drug to be used in a wider range of European women with breast cancer.
Adams Respiratory Therapeutics, Inc. reports that the Food and Drug Administration (FDA) has announced that companies must stop manufacturing and distributing unapproved timed-release dosage forms containing guaifenesin.
› Verified 5 days ago
| Provider Name | Shawn P Brown |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1609910108 PECOS PAC ID: 2961554308 Enrollment ID: I20090716000362 |
News Archive
Postmenopausal estrogen-based hormone therapy lasting longer than ten years was associated with a decreased risk of Alzheimer's disease in a large study carried out at the University of Eastern Finland.
Medical education in sub-Saharan Africa is being revitalized and expanded through a U.S.-funded effort that is dramatically increasing enrollment, broadening curricula, upgrading Internet access and providing cutting-edge skills labs and other technologies.
European women suffering from breast cancer will soon have access to the breast cancer drug Arimidex after British authorities granted approval for the drug to be used in a wider range of European women with breast cancer.
Adams Respiratory Therapeutics, Inc. reports that the Food and Drug Administration (FDA) has announced that companies must stop manufacturing and distributing unapproved timed-release dosage forms containing guaifenesin.
› Verified 5 days ago
| Provider Name | Joseph G Grau |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1508868456 PECOS PAC ID: 8426173022 Enrollment ID: I20100920001007 |
News Archive
Postmenopausal estrogen-based hormone therapy lasting longer than ten years was associated with a decreased risk of Alzheimer's disease in a large study carried out at the University of Eastern Finland.
Medical education in sub-Saharan Africa is being revitalized and expanded through a U.S.-funded effort that is dramatically increasing enrollment, broadening curricula, upgrading Internet access and providing cutting-edge skills labs and other technologies.
European women suffering from breast cancer will soon have access to the breast cancer drug Arimidex after British authorities granted approval for the drug to be used in a wider range of European women with breast cancer.
Adams Respiratory Therapeutics, Inc. reports that the Food and Drug Administration (FDA) has announced that companies must stop manufacturing and distributing unapproved timed-release dosage forms containing guaifenesin.
› Verified 5 days ago
| Provider Name | Arvinder Chani |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1487655775 PECOS PAC ID: 2365634169 Enrollment ID: I20101012001057 |
News Archive
Postmenopausal estrogen-based hormone therapy lasting longer than ten years was associated with a decreased risk of Alzheimer's disease in a large study carried out at the University of Eastern Finland.
Medical education in sub-Saharan Africa is being revitalized and expanded through a U.S.-funded effort that is dramatically increasing enrollment, broadening curricula, upgrading Internet access and providing cutting-edge skills labs and other technologies.
European women suffering from breast cancer will soon have access to the breast cancer drug Arimidex after British authorities granted approval for the drug to be used in a wider range of European women with breast cancer.
Adams Respiratory Therapeutics, Inc. reports that the Food and Drug Administration (FDA) has announced that companies must stop manufacturing and distributing unapproved timed-release dosage forms containing guaifenesin.
› Verified 5 days ago
| Provider Name | Dawn Garrett-wright |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1033509393 PECOS PAC ID: 6507182250 Enrollment ID: I20150224001721 |
News Archive
Postmenopausal estrogen-based hormone therapy lasting longer than ten years was associated with a decreased risk of Alzheimer's disease in a large study carried out at the University of Eastern Finland.
Medical education in sub-Saharan Africa is being revitalized and expanded through a U.S.-funded effort that is dramatically increasing enrollment, broadening curricula, upgrading Internet access and providing cutting-edge skills labs and other technologies.
European women suffering from breast cancer will soon have access to the breast cancer drug Arimidex after British authorities granted approval for the drug to be used in a wider range of European women with breast cancer.
Adams Respiratory Therapeutics, Inc. reports that the Food and Drug Administration (FDA) has announced that companies must stop manufacturing and distributing unapproved timed-release dosage forms containing guaifenesin.
› Verified 5 days ago
| Provider Name | Kimberly A Link |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1063584209 PECOS PAC ID: 5890893135 Enrollment ID: I20150309002612 |
News Archive
Postmenopausal estrogen-based hormone therapy lasting longer than ten years was associated with a decreased risk of Alzheimer's disease in a large study carried out at the University of Eastern Finland.
Medical education in sub-Saharan Africa is being revitalized and expanded through a U.S.-funded effort that is dramatically increasing enrollment, broadening curricula, upgrading Internet access and providing cutting-edge skills labs and other technologies.
European women suffering from breast cancer will soon have access to the breast cancer drug Arimidex after British authorities granted approval for the drug to be used in a wider range of European women with breast cancer.
Adams Respiratory Therapeutics, Inc. reports that the Food and Drug Administration (FDA) has announced that companies must stop manufacturing and distributing unapproved timed-release dosage forms containing guaifenesin.
› Verified 5 days ago
| Provider Name | Melissa J Mathews |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1235339151 PECOS PAC ID: 7911201009 Enrollment ID: I20170428001436 |
News Archive
Postmenopausal estrogen-based hormone therapy lasting longer than ten years was associated with a decreased risk of Alzheimer's disease in a large study carried out at the University of Eastern Finland.
Medical education in sub-Saharan Africa is being revitalized and expanded through a U.S.-funded effort that is dramatically increasing enrollment, broadening curricula, upgrading Internet access and providing cutting-edge skills labs and other technologies.
European women suffering from breast cancer will soon have access to the breast cancer drug Arimidex after British authorities granted approval for the drug to be used in a wider range of European women with breast cancer.
Adams Respiratory Therapeutics, Inc. reports that the Food and Drug Administration (FDA) has announced that companies must stop manufacturing and distributing unapproved timed-release dosage forms containing guaifenesin.
› Verified 5 days ago
| Provider Name | Jordan Embry |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1508239070 PECOS PAC ID: 3274918982 Enrollment ID: I20220916000641 |
News Archive
Postmenopausal estrogen-based hormone therapy lasting longer than ten years was associated with a decreased risk of Alzheimer's disease in a large study carried out at the University of Eastern Finland.
Medical education in sub-Saharan Africa is being revitalized and expanded through a U.S.-funded effort that is dramatically increasing enrollment, broadening curricula, upgrading Internet access and providing cutting-edge skills labs and other technologies.
European women suffering from breast cancer will soon have access to the breast cancer drug Arimidex after British authorities granted approval for the drug to be used in a wider range of European women with breast cancer.
Adams Respiratory Therapeutics, Inc. reports that the Food and Drug Administration (FDA) has announced that companies must stop manufacturing and distributing unapproved timed-release dosage forms containing guaifenesin.
› Verified 5 days ago
| Provider Name | Kate M Spurling |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1881914448 PECOS PAC ID: 9739211152 Enrollment ID: I20230710000267 |
News Archive
Postmenopausal estrogen-based hormone therapy lasting longer than ten years was associated with a decreased risk of Alzheimer's disease in a large study carried out at the University of Eastern Finland.
Medical education in sub-Saharan Africa is being revitalized and expanded through a U.S.-funded effort that is dramatically increasing enrollment, broadening curricula, upgrading Internet access and providing cutting-edge skills labs and other technologies.
European women suffering from breast cancer will soon have access to the breast cancer drug Arimidex after British authorities granted approval for the drug to be used in a wider range of European women with breast cancer.
Adams Respiratory Therapeutics, Inc. reports that the Food and Drug Administration (FDA) has announced that companies must stop manufacturing and distributing unapproved timed-release dosage forms containing guaifenesin.
› Verified 5 days ago
News Archive
Postmenopausal estrogen-based hormone therapy lasting longer than ten years was associated with a decreased risk of Alzheimer's disease in a large study carried out at the University of Eastern Finland.
Medical education in sub-Saharan Africa is being revitalized and expanded through a U.S.-funded effort that is dramatically increasing enrollment, broadening curricula, upgrading Internet access and providing cutting-edge skills labs and other technologies.
European women suffering from breast cancer will soon have access to the breast cancer drug Arimidex after British authorities granted approval for the drug to be used in a wider range of European women with breast cancer.
Adams Respiratory Therapeutics, Inc. reports that the Food and Drug Administration (FDA) has announced that companies must stop manufacturing and distributing unapproved timed-release dosage forms containing guaifenesin.
› Verified 5 days ago
Healing Path Counseling Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 741 William Simmons Rd, Bowling Green, KY 42101 Phone: 270-202-1096 | |
The Luna Therapy & Wellness Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2530 Scottsville Rd Ste 22, Bowling Green, KY 42104 Phone: 270-864-6872 | |
Restoration Counseling Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1830 Destiny Ln, Bowling Green, KY 42104 Phone: 270-846-3222 Fax: 270-846-3228 | |
Casey Coursey Lcsw Emdr Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 410 E 10th Ave # 2c, Bowling Green, KY 42101 Phone: 364-203-8188 Fax: 949-437-3743 | |
Interventional Pain Specialists Of Bowling Green Plc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 165 Natchez Trace Ave, Suite 205, Bowling Green, KY 42103 Phone: 270-393-1912 Fax: 270-393-1913 | |
More To Life Counseling Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 351 Pascoe Blvd, Suite 103h, Bowling Green, KY 42104 Phone: 270-791-5933 Fax: 270-721-0988 | |
Nurtured Counseling Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 109 Stoney Ct, Bowling Green, KY 42101 Phone: 270-200-0822 |